Industry interviews
3markets assessed
Ask the strategists
We interviewed regulatory strategists and government affairs leaders at international drug makers.
Case Study · Regulatory Intelligence
Reading the future of drug regulation.
A major biotechnology company wanted to know how drug development regulation would evolve after Brexit and other international changes. We combined expert interviews with a machine learning analysis of clinical trial trends.
The Client
The client is a major biotechnology company. It wanted to know how regulatory changes could affect its business.
The Challenge
Shifting rules.
See what comes next.
Prescouter was asked to explain how the drug development regulatory landscape in the EU, UK and US will evolve in the face of Brexit and other international developments.
-
Industry
Industry views
What drug makers expect.
-
Regulators
Agency outlook
How regulators see the field.
-
Data
Trial trends
What clinical trial data shows.
Our Approach
Testing expert views against clinical trial data.
Regulator interviews
Directviews from regulators
Hear from regulators
Executives at regulatory bodies shared how they expect the field to change.
Machine learning
MLtrial trend analysis
Model the shocks
We measured how trial size, length, start rate and success shifted after events like Brexit.
The Outcome
A guide to the rules ahead.
Prescouter delivered a data driven model showing where expert consensus matched clinical trial trends and where they diverged. The client gained a full view of the changes it was weighing and a guide to the regulatory events likely to affect its business.
-
Model
Data driven model
Experts tested against trial data.
-
Clarity
Consensus and gaps
Where views and data diverge.
-
Guide
Events to watch
Regulatory shifts that matter.
Expert opinion and hard data rarely agree on everything. Where they split is often where the real risk sits.
Let’s Talk
How will new regulations shape your pipeline?
Pair expert views with hard data and prepare for the changes that matter. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]